Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor admin Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor Read More »
APL-102, an oral small molecule multi-kinase inhibitor, demonstrates favorable CSF-1R activity, offering a means for controlling tumor associated macrophages admin APL-102, an oral small molecule multi-kinase inhibitor, demonstrates favorable CSF-1R activity, offering a means for controlling tumor associated macrophages Read More »
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor admin Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor Read More »
